389 related articles for article (PubMed ID: 12239179)
1. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
Hennig H; Puchta I; Luhm J; Schlenke P; Goerg S; Kirchner H
Blood; 2002 Oct; 100(7):2637-41. PubMed ID: 12239179
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
[TBL] [Abstract][Full Text] [Related]
3. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
Kuhns MC; Busch MP
Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
6. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
8. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
9. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers.
Arraes LC; Ximenes R; Andrieu JM; Lu W; Barreto S; Pereira LM; Castelo A
Rev Inst Med Trop Sao Paulo; 2003; 45(3):137-40. PubMed ID: 12870062
[TBL] [Abstract][Full Text] [Related]
10. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
12. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination.
Altunay H; Kosan E; Birinci I; Aksoy A; Kirali K; Saribas S; Aslan M; Yuksel P; Alan E; Yenen OS; Kocazeybek B
Transfus Apher Sci; 2010 Dec; 43(3):265-268. PubMed ID: 20934912
[TBL] [Abstract][Full Text] [Related]
13. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya.
El-Nabi SH; El-Garawani I; Ismail F; Abdelsameea E
Transfus Med; 2020 Oct; 30(5):401-405. PubMed ID: 32894893
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
Stolz M; Tinguely C; Fontana S; Niederhauser C
Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
[TBL] [Abstract][Full Text] [Related]
15. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
[TBL] [Abstract][Full Text] [Related]
20. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.
Hedayati-Moghaddam MR; Tehranian F; Mosavat A; Miri R; Ahmadi Ghezeldasht S
Arch Iran Med; 2024 Jun; 27(6):305-312. PubMed ID: 38855800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
